Dr. Erdal Bozdoğan, the recently appointed general manager of Takeda Turkey, leverages his 20 years of experience in the pharmaceutical industry and his expertise of emerging markets to document Turkey’s attractiveness for Takeda and how, as a doctor, his patient orientated mindset is “no longer a dream but a reality”, further highlighting Turkey as a crucial country for the company and their ever-increasing focus on specialty care.
With your extensive knowledge of different emerging countries, what is your assessment of Turkey as a typical pharmaemerging market?
"[Turkey] stands out for its well-established regulations, which contributed to establishing it as a role model among other emerging countries such as South Korea and Taiwan"
